entertainment -WSS

entertainment

author：leisure time 2025-09-28 00:51:28 - browse：539

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Wikipedia

WSS

Hearing on Medicare drug price negotiation gets unusually heated

Too many hospitalized Covid

STAT Boddities: What happens to the brain when we get scared?

Ebola vaccine can save some who are already sick, per new study

Why Eli Lilly’s earnings didn’t quite live up to the hype

Readout LOUD podcast: possible new ALS drug, artificial wombs

hotspot

entertainment

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Heart attack and stroke risk calculators need revising

How Vertex's cystic fibrosis drug is changing patients' lives

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Boddities: What happens to the brain when we get scared?

Moonlake's readout produced a cash windfall. Risks remain

Long Covid research funding gets a major boost from NIH

As demand for Covid shots wanes, Moderna seeks its next success

Congress might make insulin pumps more accessible to the blind

entertainment

CDC's new outbreak response network to include Northeastern

Report cites 'urgent' need to recruit more diverse clinical trial participants

Long Covid research funding gets a major boost from NIH

CDC's new outbreak response network to include Northeastern

Juul documents reveal insider tactics on political lobbying

How AI helped researchers track recovery from depression

knowledge

Wikipedia

leisure time

Wikipedia